期刊
CURRENT EYE RESEARCH
卷 21, 期 5, 页码 886-890出版社
TAYLOR & FRANCIS INC
DOI: 10.1076/ceyr.21.5.886.5538
关键词
cathepsins; conjunctiva; keratoconus; protease inhibitors; transcription factor
资金
- NEI NIH HHS [EY 03890, EY 01792, EY 05628] Funding Source: Medline
- NATIONAL EYE INSTITUTE [P30EY001792, R01EY003890] Funding Source: NIH RePORTER
Purpose. In keratoconus corneas, it has been shown that levels of degradative enzymes and transcription factor Sp1 are elevated and those of inhibitors are reduced, especially in the epithelial layer. This study is to determine whether the biochemical abnormalities identified in corneas also exist in conjunctival tissues. Methods. Conjunctival tissues were collected from normal subjects and from patients with keratoconus, senile cataract, and other corneal diseases. Immunohistochemical staining for cathepsins B and G, alpha1-proteinase inhibitor, alpha2-macroglobulin and Sp1 was performed. Results. The epithelium of all conjunctival specimens showed immunoreactivity toward the antibodies. The staining for cathepsins B and G, and the inhibitors was mostly cytoplasmic, while that for Sp1 was nuclear. The staining intensity in keratoconus specimens was all within normal range. Conclusions. These results suggest that the abnormalities in cathepsins B and G, protease inhibitors and Sp1 identified in keratoconus corneas are not manifested in the conjunctiva. Keratoconus appears to be a disease localized to the cornea.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据